Ceftobiprole in the Treatment of Patients With Acute Bacterial Skin and Skin Structure Infections
Status:
Completed
Trial end date:
2019-04-22
Target enrollment:
Participant gender:
Summary
This was a randomized, double-blind, active-controlled, parallel-group, multicenter study in
adult hospitalized patients to establish the safety and efficacy of ceftobiprole medocaril
compared with vancomycin plus aztreonam in the treatment of acute bacterial skin and skin
structure infections (ABSSSIs).